Eva Hellström-Lindberg

appreci8: a pipeline for precise variant calling integrating 8 tools

Julian Varghese, Christian Rohde, Martin Dugas, 2018, Bioinform..

Using a Hematology Curriculum in a Web Portfolio Environment

Fredrik Enoksson, Ambjörn Naeve, Eva Hellström-Lindberg, 2011 .

TP53 mutations in low-risk myelodysplastic syndromes with del(5q) predict disease progression.

Eva Hellström-Lindberg, Brigitte Schlegelberger, Anette Hedlund, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

The Role of the Iron Transporter ABCB7 in Refractory Anemia with Ring Sideroblasts

Luca Malcovati, Eva Hellström-Lindberg, Mario Cazzola, 2008, PloS one.

Clinical significance of SF3B1 mutations in myelodysplastic syndromes and myelodysplastic/myeloproliferative neoplasms

Peter J Campbell, Michael R Stratton, Luca Malcovati, 2011, Blood.

The WHO classification of MDS does make a difference.

Robert B Howe, Eva Hellström-Lindberg, E. Hellström-Lindberg, 2004, Blood.

Pseudouridylation of tRNA-Derived Fragments Steers Translational Control in Stem Cells

Jenny Hansson, Shamit Soneji, Göran Karlsson, 2018, Cell.

Implications of TP53 allelic state for genome stability, clinical presentation and outcomes in myelodysplastic syndromes

Benjamin L. Ebert, Michael R. Savona, John M. Bennett, 2019, Nature Medicine.

Cobalt release from glazed earthenware: Observations in a case of lead poisoning.

Eva Hellström-Lindberg, E. Hellström-Lindberg, Anders I Seldén, 2007, Environmental toxicology and pharmacology.

Gene expression and risk of leukemic transformation in myelodysplasia.

Satoru Miyano, Yuichi Shiraishi, Kenichi Chiba, 2017, Blood.